• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前的抗病毒药物及其在生物材料中的分析 - 第一部分:抗呼吸道和疱疹病毒的抗病毒药物。

Current antiviral drugs and their analysis in biological materials-Part I: Antivirals against respiratory and herpes viruses.

机构信息

Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.

Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.

出版信息

J Pharm Biomed Anal. 2018 Jan 5;147:400-416. doi: 10.1016/j.jpba.2017.06.071. Epub 2017 Jul 3.

DOI:10.1016/j.jpba.2017.06.071
PMID:28755849
Abstract

This review article is the first in the series providing an overview of currently used antiviral drugs and presenting contemporary approaches to their analysis. Large number of available antivirals and their structural variability makes this task very challenging. Trying to cover this topic comprehensively while maintaining reasonable size of the article, the review is presented in two parts. For the purpose of the overall review, antivirals were divided into four groups: (i) antivirals against herpes viruses, (ii) antivirals against respiratory viruses, (iii) antivirals against hepatitis viruses, and (iv) antivirals against HIV. Part one is devoted to the groups (i) and (ii) and also concerns the key features of the bioanalytical method. The mechanisms of action of antivirals against respiratory and herpes viruses and their use in clinical practice are briefly outlined, and the analytical methods for selected representatives of each class are described in more detail. The methods developed for the determination of drugs from these classes mostly include conventional procedures. In contrast, current trends such as UHPLC are used rarely and proper method validation based on requirements of bioanalytical guidelines can be often considered insufficient.

摘要

这篇综述文章是系列文章的第一篇,旨在概述目前使用的抗病毒药物,并介绍其分析的现代方法。大量现有的抗病毒药物及其结构的可变性使得这项任务极具挑战性。为了全面涵盖这一主题,同时保持文章的合理篇幅,本综述分为两部分。为了全面综述的目的,将抗病毒药物分为四组:(i)抗疱疹病毒药物,(ii)抗呼吸道病毒药物,(iii)抗肝炎病毒药物,和(iv)抗 HIV 药物。第一部分专门讨论了第(i)组和第(ii)组,并涉及到生物分析方法的关键特征。简要概述了抗呼吸道和疱疹病毒药物的作用机制及其在临床实践中的应用,并详细描述了每类药物的代表性药物的分析方法。这些类别的药物的测定方法主要包括常规程序。相比之下,超高效液相色谱法等当前趋势很少使用,并且根据生物分析指南的要求进行适当的方法验证通常被认为是不够的。

相似文献

1
Current antiviral drugs and their analysis in biological materials-Part I: Antivirals against respiratory and herpes viruses.当前的抗病毒药物及其在生物材料中的分析 - 第一部分:抗呼吸道和疱疹病毒的抗病毒药物。
J Pharm Biomed Anal. 2018 Jan 5;147:400-416. doi: 10.1016/j.jpba.2017.06.071. Epub 2017 Jul 3.
2
Current antiviral drugs and their analysis in biological materials - Part II: Antivirals against hepatitis and HIV viruses.当前的抗病毒药物及其在生物材料中的分析 - 第二部分:抗肝炎和 HIV 病毒的抗病毒药物。
J Pharm Biomed Anal. 2018 Jan 5;147:378-399. doi: 10.1016/j.jpba.2017.07.003. Epub 2017 Jul 8.
3
Antivirals against DNA viruses (hepatitis B and the herpes viruses).抗DNA病毒(乙型肝炎病毒和疱疹病毒)的抗病毒药物。
Curr Opin Pharmacol. 2004 Oct;4(5):453-64. doi: 10.1016/j.coph.2004.06.004.
4
Antiviral drugs in pediatrics.儿科抗病毒药物
Am J Dis Child. 1989 Nov;143(11):1307-16. doi: 10.1001/archpedi.1989.02150230065025.
5
Antivirals in the transplant setting.移植环境中的抗病毒药物。
Antiviral Res. 2006 Sep;71(2-3):192-200. doi: 10.1016/j.antiviral.2006.04.016. Epub 2006 May 15.
6
Approaches to therapy of viral infections.病毒感染的治疗方法。
Adv Pediatr. 1987;34:89-110.
7
[Viruses and antiviral drug resistance].[病毒与抗病毒药物耐药性]
Duodecim. 2002;118(9):911-8.
8
Antiviral drugs.抗病毒药物。
N Engl J Med. 1999 Apr 22;340(16):1255-68. doi: 10.1056/NEJM199904223401608.
9
Summary of the III International Consensus Symposium on Combined Antiviral Therapy.第三届联合抗病毒治疗国际共识研讨会综述
Antiviral Res. 1998 May;38(2):75-93. doi: 10.1016/s0166-3542(98)00021-7.
10
Achievements and challenges in antiviral drug discovery.抗病毒药物研发的成就与挑战。
Antivir Chem Chemother. 2005;16(3):155-68. doi: 10.1177/095632020501600302.

引用本文的文献

1
Sensitive detection of amantadine in food matrices using DTT-functionalized gold nanoparticles.使用二硫苏糖醇功能化金纳米颗粒灵敏检测食品基质中的金刚烷胺。
RSC Adv. 2025 Aug 26;15(37):30404-30414. doi: 10.1039/d5ra05197e. eCollection 2025 Aug 22.
2
Antiviral activity of Azadirachta indica A. Juss and Melia azedarach extracts during the replication cycle of small ruminant lentiviruses.印度楝和苦楝提取物在小反刍兽疫病毒复制周期中的抗病毒活性。
Braz J Microbiol. 2025 Apr 26. doi: 10.1007/s42770-025-01659-0.
3
Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19).
加速重新利用美国食品药品监督管理局(FDA)批准的药物来对抗冠状病毒病(COVID-19)。
RSC Adv. 2020 Nov 10;10(67):40867-40875. doi: 10.1039/d0ra09010g. eCollection 2020 Nov 9.
4
Determination of Antiviral Drugs and Their Metabolites Using Micro-Solid Phase Extraction and UHPLC-MS/MS in Reversed-Phase and Hydrophilic Interaction Chromatography Modes.采用微固相萃取和反相及亲水作用色谱模式下的 UHPLC-MS/MS 测定抗病毒药物及其代谢物。
Molecules. 2021 Apr 7;26(8):2123. doi: 10.3390/molecules26082123.
5
SARS-CoV-2: What do we know so far?新型冠状病毒(SARS-CoV-2):我们目前了解到了什么?
Acta Physiol (Oxf). 2020 Jun;229(2):e13470. doi: 10.1111/apha.13470. Epub 2020 Apr 11.
6
Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices.抗 HIV 和抗丙型肝炎病毒药物抑制 Caco-2 细胞和精密切割大鼠及人肠切片中的 P-糖蛋白外排活性。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00910-19. Print 2019 Nov.
7
Antiretroviral Concentration in Hair as a Measure for Antiretroviral Medication Adherence: A Systematic Review of Global Literature.头发中抗逆转录病毒浓度作为抗逆转录病毒药物依从性的衡量指标:全球文献的系统评价。
AIDS Behav. 2020 Jan;24(1):311-330. doi: 10.1007/s10461-019-02460-5.
8
Antiviral Activities of Oleanolic Acid and Its Analogues.齐墩果酸及其类似物的抗病毒活性。
Molecules. 2018 Sep 9;23(9):2300. doi: 10.3390/molecules23092300.